Literature DB >> 6187790

Induction of late cutaneous reaction by kallikrein injection: comparison with allergic-like late response to compound 48/80.

P J Dor, D Vervloet, M Sapene, L Andrac, J J Bonerandi, J Charpin.   

Abstract

Although IgE antibody is able to provoke a late cutaneous allergic response (LCAR), the mechanism of its development is not clear. It seems to involve vasoactive and clotting mediators released from mast cells and basophils. Substances biologically similar to plasma kallikrein (KK), a Hageman factor activator, have been shown to be released by basophils in the course of an IgE-dependent reaction. Because compound 48/80 induces LCAR-like responses in the skin, we compared the ability of tissue KK and compound 48/80 to induce late cutaneous reactions (LCRs). All 40 test subjects showed an immediate wheal and flare reaction (WF) after both KK and 48/80. The WF was followed by an LCR characterized by diffuse edema, pain, and erythema in 36 of 40 subjects with 48/80 and 26 of 40 with KK. The LCRs evoked by the two agents did not differ in their appearance or in their time of development. These reactions increased until the 5 hr mark, began to decrease at the 10 hr mark, and were gone after 24 hr. Histologic study showed edema and a mixed cell infiltration with fibrin deposition. Challenge of the original injection site and a new site after 1 or 2 wk showed a local refractory state lasting 2 wk. Prednisone almost totally suppressed the LCRs induced by both KK and 48/80.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6187790     DOI: 10.1016/0091-6749(83)90063-5

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  8 in total

1.  Failure to detect deposition of complement and immunoglobulin in allergen-induced late-phase skin reaction in atopic subjects.

Authors:  A J Frew; A B Kay
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

2.  The effects of drugs on leucocyte changes following the injection of antigen into the peritoneal cavities of actively sensitised rats.

Authors:  B A Spicer; S M Laycock; H Smith
Journal:  Agents Actions       Date:  1986-03

3.  Cutaneous reactions to kallikrein and histamine in patients with urticaria.

Authors:  S Imai
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

Review 4.  Urticaria and angioedema.

Authors:  B A Burrall; A C Huntley
Journal:  Clin Rev Allergy       Date:  1985-02

5.  Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration.

Authors:  E N Charlesworth; A F Hood; N A Soter; A Kagey-Sobotka; P S Norman; L M Lichtenstein
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

Review 6.  Late-phase IgE-mediated reactions.

Authors:  R F Lemanske; M Kaliner
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

7.  Inflammatory mechanisms in the passive cutaneous anaphylactic reaction in the rabbit: evidence that novel mediators are involved.

Authors:  P G Hellewell; P J Jose; T J Williams
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

8.  Investigation of the endogenous chemoattractants involved in 111In-eosinophil accumulation in passive cutaneous anaphylactic reactions in the guinea-pig.

Authors:  V B Weg; M L Watson; L H Faccioli; T J Williams
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.